Investigation of the antidepressant effects of exopolysaccharides obtained from Marasmius androsaceus fermentation in a mouse model

Song,Jia; Xing,Gaoyang; Cao,Jiaming; Teng,Lirong; Li,Chenliang; Meng,Qingfan; Lu,Jiahui; Zhou,Yulin; Liu,Yang; Wang,Di; Teng,Lesheng

doi:10.3892/mmr.2015.4584

Investigation of the antidepressant effects of exopolysaccharides obtained from Marasmius androsaceus fermentation in a mouse model

Authors:
- Jia Song
- Gaoyang Xing
- Jiaming Cao
- Lirong Teng
- Chenliang Li
- Qingfan Meng
- Jiahui Lu
- Yulin Zhou
- Yang Liu
- Di Wang
- Lesheng Teng
View Affiliations

Affiliations: School of Life Sciences, Jilin University, Changchun, Jilin 130012, P.R. China
Published online on: November 19, 2015 https://doi.org/10.3892/mmr.2015.4584
Pages: 939-946

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Marasmius androsaceus, a well‑known medical fungus, possesses antihypertensive, analgesic and antioxidant effects. Exopolysaccharide (EPS), produced by microorganism secretion, exerts various types of biological activities. The present study aimed to investigate the antidepressant‑like effect of the EPS produced during Marasmius androsaceus submerge fermentation (MEPS). Based on the assessment of acute toxicity and behavior, a forced swimming test (FST), tail suspension test (TST), 5‑hydroxytryptophan‑induced head‑twitch assessment and reserpine‑induced hypothermia assessment were performed. The administration of MEPS for 7 days enhanced mouse locomotor and balance ability in the mice. Similar to the results following treatment with fluoxetine, which was used as positive control drug, MEPS significantly decreased the duration of immobility in the FST and TST, increased head twitches in the 5‑HTP‑induced head‑twitch test and enhanced rectal temperature in resperpine‑induced hypothermia. MEPS altered the abnormal concentrations of 5‑hydroxytryptamine, 5‑hydroxyindoleacetic acid, dopamine and norepinephrine in the hypothalamus in the resperine‑induced mouse model. Additionally, an increase in the expression of tyrosine hydroxylase and a reduction in the level of dopamine transporter in the hypothalamus were noted following 7 days of MEPS administration. Taken together, the EPS produced during MEPS exhibited antidepressant‑like effects, which may be associated with its regulation on the dopaminergic system. The results of the present study provide experimental evidence supporting the clinical use of MEPS as an effective agent against depression.

View Figures

View References

1	Réus GZ, Vieira FG, Abelaira HM, Michels M, Tomaz DB, dos Santos MA, Carlessi AS, Neotti MV, Matias BI, Luz JR, et al: MAPK signaling correlates with the antidepressant effects of ketamine. J Psychiatr Res. 55:15–21. 2014. View Article : Google Scholar : PubMed/NCBI
2	Kessler RC and Wang PS: The descriptive epidemiology of commonly occurring mental disorders in the United States. Ann Rev Public Health. 29:115–129. 2008. View Article : Google Scholar
3	Manji HK, Drevets WC and Charney DS: The cellular neurobiology of depression. Nat Med. 7:541–547. 2001. View Article : Google Scholar : PubMed/NCBI
4	Steru L, Chermat R, Thierry B and Simon P: The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl). 85:367–370. 1985. View Article : Google Scholar
5	Komiya M, Takeuchi T and Harada E: Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice. Behav Brain Res. 172:240–249. 2006. View Article : Google Scholar : PubMed/NCBI
6	Ma Z, Ji W, Qu R, Wang M, Yang W, Zhan Z, Fu Q and Ma S: Metabonomic study on the antidepressant-like effects of banxia houpu decoction and its action mechanism. Evid Based Complement Alternat Med. 2013:2137392013. View Article : Google Scholar : PubMed/NCBI
7	Kang A, Hao H, Zheng X, Liang Y, Xie Y, Xie T, Dai C, Zhao Q, Wu X, Xie L and Wang G: Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy. J Neuroinflammation. 8:1002011. View Article : Google Scholar : PubMed/NCBI
8	Kennedy SH: A review of antidepressant treatments today. Eur Neuropsychopharm. 16(Suppl): S619–S623. 2006. View Article : Google Scholar
9	Novak M and Vetvicka V: Beta-glucans, history and the present: Immunomodulatory aspects and mechanisms of action. J Immunotoxicol. 5:47–57. 2008. View Article : Google Scholar : PubMed/NCBI
10	Jin L, Wu F, Li X, Li H, Du C, Jiang Q, You J, Li S and Xu Y: Anti-depressant effects of aqueous extract from Acanthopanax senticosus in mice. Phytother Res. 27:1829–1833. 2013. View Article : Google Scholar : PubMed/NCBI
11	Dar A, Khatoon S, Rahman G and Atta-Ur-Rahman: Anti-depressant activities of areca catechu fruit extract. Phytomedicine. 4:41–45. 1997. View Article : Google Scholar : PubMed/NCBI
12	Peng L, Zhang X, Kang DY, Liu XT and Hong Q: Effectiveness and safety of wuling capsule for post stroke depression: A systematic review. Complement Ther Med. 22:549–566. 2014. View Article : Google Scholar : PubMed/NCBI
13	Wang XJ, Li J, Zou QD and Jin L: Wuling capsule for climacteric patients with depression and anxiety state: A randomized, positive parallel controlled trial. Zhong Xi Yi Jie He Xue Bao. 7:1042–1046. 2009.In Chinese. View Article : Google Scholar : PubMed/NCBI
14	Wang X, Liang QM, Li TT, Zhi R, Zhang N and Lu J: Study on extraction and anti-oxidation of Marasmius androsaceus mycelium polysaccharides. Food Sci Technol. 12:80–83. 2006.
15	Ye WF, Yang XT, Chen Y and Li QL: Long-time analgesic effect of Marasmius androsaceus in rats. Zhong yao yao li yu lin chuang. 18:19–21. 2002.In Chinese.
16	Gao Yang YX-l and Xu Duo-Duo: Glycopeptide physicochemical properties and analgesic effect of Marasmius androsaceus. Changchun Zhong yi xue yuan xue bao. 777–778. 2013.In Chinese.
17	Kim SW, Hwang HJ, Xu CP, Sung JM, Choi JW and Yun JW: Optimization of submerged culture process for the production of mycelial biomass and exo-polysaccharides by Cordyceps militaris C738. J Appl Microbiol. 94:120–126. 2003. View Article : Google Scholar
18	Chen H, Yan M, Zhu J and Xu X: Enhancement of exo-polysaccharide production and antioxidant activity in submerged cultures of Inonotus obliquus by lignocellulose decomposition. J Ind Microbiol Biotechnol. 38:291–298. 2011. View Article : Google Scholar
19	Shih IL: Microbial exo-polysaccharides for biomedical applications. Mini Rev Med Chem. 10:1345–1355. 2010. View Article : Google Scholar : PubMed/NCBI
20	Sun Na-Xin YG-W and An Li-Guo: Anti-hyperglycemic activities of exopolysaccharides from Cordyceps militaris in diabetic mice induced by multiple low-dose streptozotocoin. Shipin Kexue (Beijing). 288–295. 2013.In Chinese.
21	Lan Ying PZ-F, Zhang Song and Yang Xiao-Bing: The Influence of exopolysaccharide extract of Morchella conica on fruit Fly's life-span. Zhong guo shi yong jun bian ji bu. 43–45. 2010.In Chinese.
22	Yan H, Zhu D, Xu D, Wu J and Bian X: A study on Cordyceps militaris polysaccharide purification, composition and activity analysis. Afr J Biotechnol. 7:4004–4009. 2008.
23	Porsolt RD, Bertin A and Jalfre M: Behavioral despair in mice: A primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 229:327–336. 1977.PubMed/NCBI
24	Pesarico AP, Sampaio TB, Stangherlin EC, Mantovani AC, Zeni G and Nogueira CW: The antidepressant-like effect of 7-fluoro-1,3-diphenylisoquinoline-1-amine in the mouse forced swimming test is mediated by serotonergic and dopaminergic systems. Prog Neuropsychopharmacol Biol Psychiatry. 54:179–186. 2014. View Article : Google Scholar : PubMed/NCBI
25	Xiang H, Liu Y, Zhang B, Huang J, Li Y, Yang B, Huang Z, Xiang F and Zhang H: The antidepressant effects and mechanism of action of total saponins from the caudexes and leaves of Panax notoginseng in animal models of depression. Phytomedicine. 18:731–738. 2011. View Article : Google Scholar : PubMed/NCBI
26	Yang CL, Chik SC, Li JC, Cheung BK and Lau AS: Identification of the bioactive constituent and its mechanisms of action in mediating the anti-inflammatory effects of black cohosh and related Cimicifuga species on human primary blood macrophages. J Med Chem. 52:6707–6715. 2009. View Article : Google Scholar : PubMed/NCBI
27	Noble JE and Bailey MJ: Quantitation of protein. Methods Enzymol. 463:73–95. 2009. View Article : Google Scholar : PubMed/NCBI
28	Gao L, Liu G, Kang J, Niu M, Wang Z, Wang H, Ma J and Wang X: Paclitaxel nanosuspensions coated with P-gp inhibitory surfactants: I. Acute toxicity and pharmacokinetics studies. Colloids Surf B Biointerfaces. 111:277–281. 2013. View Article : Google Scholar : PubMed/NCBI
29	Willner P: The validity of animal models of depression. Psychopharmacology (Berl). 83:1–16. 1984. View Article : Google Scholar
30	Gao S, Cui YL, Yu CQ, Wang QS and Zhang Y: Tetrandrine exerts antidepressant-like effects in animal models: Role of brain-derived neurotrophic factor. Behav Brain Res. 238:79–85. 2013. View Article : Google Scholar
31	Cryan JF and Lucki I: Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine (2C) receptors. J Pharmacol Exp Ther. 295:1120–1126. 2000.PubMed/NCBI
32	Page ME, Detke MJ, Dalvi A, Kirby LG and Lucki I: Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl). 147:162–167. 1999. View Article : Google Scholar
33	Handley SL and Singh L: Modulation of 5-hydroxytryptamine-induced head-twitch response by drugs acting at GABA and related receptors. Br J Pharmacol. 86:297–303. 1985. View Article : Google Scholar : PubMed/NCBI
34	Peroutka SJ, Lebovitz RM and Snyder SH: Two distinct central serotonin receptors with different physiological functions. Science. 212:827–829. 1981. View Article : Google Scholar : PubMed/NCBI
35	Fukuda K: 5-HTP hypothesis of schizophrenia. Med Hypotheses. 82:20–23. 2014. View Article : Google Scholar
36	Zhang ZJ, Wang D, Man SC, Ng R, McAlonan GM, Wong HK, Wong W, Lee J and Tan QR: Platelet 5-HT (1A) receptor correlates with major depressive disorder in drug-free patients. Prog Neuropsychopharmacol Biol Psychiatry. 53:74–79. 2014. View Article : Google Scholar : PubMed/NCBI
37	Gardier AM, Malagié I, Trillat AC, Jacquot C and Artigas F: Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: Recent findings from in vivo microdialysis studies. Fundam Clin Pharmacol. 10:16–27. 1996. View Article : Google Scholar : PubMed/NCBI
38	Rainer Q, Nguyen HT, Quesseveur G, Gardier AM, David DJ and Guiard BP: Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration. Mol Pharmacol. 81:106–112. 2012. View Article : Google Scholar
39	Haenisch B and Bönisch H: Depression and antidepressants: Insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters. Pharmacol Ther. 129:352–368. 2011. View Article : Google Scholar
40	Tashkin DP, Rabinoff M, Noble EP, Ritchie TL, Simmons MS and Connett J: Association of dopamine-related gene alleles, smoking behavior and decline in FEV1 in subjects with COPD: findings from the lung health study. COPD. 9:620–628. 2012. View Article : Google Scholar : PubMed/NCBI
41	Madras BK, Fahey MA, Miller GM, De La Garza R, Goulet M, Spealman RD, Meltzer PC, George SR, O'Dowd BF, Bonab AA, et al: Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors. Eur J Pharmacol. 479:41–51. 2003. View Article : Google Scholar : PubMed/NCBI
42	Cunha MP, Pazini FL, Oliveira Á, Bettio LE, Rosa JM, Machado DG and Rodrigues AL: The activation of α1-adrenoceptors is implicated in the antidepressant-like effect of creatine in the tail suspension test. Prog Neuropsychopharmacology Biol Psychiatry. 44:39–50. 2013. View Article : Google Scholar
43	Rovin ML, Boss-Williams KA, Alisch RS, Ritchie JC, Weinshenker D, West CH and Weiss JM: Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain. Neuropeptides. 46:81–91. 2012. View Article : Google Scholar : PubMed/NCBI
44	Nagatsu T, Levitt M and Udenfriend S: Tyrosine Hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem. 239:2910–2917. 1964.PubMed/NCBI
45	Lambert G, Johansson M, Agren H and Friberg P: Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: Evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatry. 57:787–793. 2000. View Article : Google Scholar : PubMed/NCBI
46	Ainsworth K, Smith SE, Zetterstrom TS, Pei Q, Franklin M and Sharp T: Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat. Psychopharmacology (Berl). 140:470–477. 1998. View Article : Google Scholar